US Stock MarketDetailed Quotes

Milestone Pharmaceuticals (MIST)

Watchlist
  • 1.966
  • -0.024-1.22%
Trading Jan 23 09:43 ET
167.43MMarket Cap-2.49P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Milestone Pharmaceuticals (MIST) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
-80.00%1M
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
-80.00%1M
--0
Cost of revenue
Gross profit
Operating expense
23.01%11.83M
29.69%12.53M
95.90%20.52M
-32.20%42.1M
-10.52%12.35M
-37.40%9.62M
-41.21%9.66M
-36.52%10.48M
-3.94%62.1M
-20.04%13.8M
Selling and administrative expenses
39.55%7.89M
29.43%8.86M
127.37%15.55M
-10.63%27.75M
0.72%8.41M
-34.56%5.65M
-12.38%6.85M
9.48%6.84M
25.12%31.05M
24.95%8.35M
-Selling and marketing expense
142.07%4.63M
183.34%5.1M
259.85%10.38M
-27.20%11M
-11.45%4.41M
-56.69%1.91M
-46.54%1.8M
22.41%2.88M
66.18%15.11M
94.57%4.98M
-General and administrative expense
-12.80%3.26M
-25.51%3.76M
30.71%5.17M
5.08%16.74M
18.69%4M
-11.47%3.74M
13.52%5.05M
1.65%3.95M
1.36%15.93M
-18.24%3.37M
Research and development costs
-0.58%3.94M
30.34%3.67M
36.80%4.98M
-53.76%14.36M
-27.73%3.94M
-41.04%3.96M
-67.35%2.82M
-64.52%3.64M
-22.04%31.05M
-48.46%5.45M
Operating profit
-23.01%-11.83M
-29.69%-12.53M
-95.90%-20.52M
31.09%-42.1M
10.52%-12.35M
37.40%-9.62M
41.21%-9.66M
32.42%-10.48M
-2.44%-61.1M
-0.30%-13.8M
Net non-operating interest income expense
-152.54%-93K
-245.48%-435K
-295.08%-238K
-58.74%583K
-107.94%-15K
-36.56%177K
-23.92%299K
-77.90%122K
12.68%1.41M
-67.53%189K
Non-operating interest income
-19.07%874K
-56.49%516K
-29.88%697K
4.97%4.16M
-13.58%904K
-3.57%1.08M
-2.23%1.19M
69.91%994K
216.35%3.97M
79.73%1.05M
Non-operating interest expense
7.09%967K
7.22%951K
7.22%935K
40.21%3.58M
7.23%919K
7.37%903K
8.17%887K
2,542.42%872K
--2.55M
--857K
Other net income (expense)
Income before tax
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
30.44%-41.52M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
Income tax
Net income
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
30.44%-41.52M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
Net income continuous Operations
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
30.44%-41.52M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
Minority interest income
Net income attributable to the parent company
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
30.44%-41.52M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-26.31%-11.92M
-38.48%-12.97M
-100.51%-20.76M
30.44%-41.52M
9.17%-12.36M
37.41%-9.44M
41.64%-9.36M
30.74%-10.35M
-2.22%-59.69M
-3.29%-13.61M
Basic earnings per share
14.29%-0.12
-42.86%-0.2
-47.62%-0.31
51.80%-0.67
40.63%-0.19
60.00%-0.14
62.16%-0.14
40.00%-0.21
-0.72%-1.39
-3.23%-0.32
Diluted earnings per share
14.29%-0.12
-42.86%-0.2
-47.62%-0.31
51.80%-0.67
40.63%-0.19
60.00%-0.14
62.16%-0.14
40.00%-0.21
-0.72%-1.39
-3.23%-0.32
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 00000000-80.00%1M0
Operating revenue --0--0--0--0--0--0--0--0-80.00%1M--0
Cost of revenue
Gross profit
Operating expense 23.01%11.83M29.69%12.53M95.90%20.52M-32.20%42.1M-10.52%12.35M-37.40%9.62M-41.21%9.66M-36.52%10.48M-3.94%62.1M-20.04%13.8M
Selling and administrative expenses 39.55%7.89M29.43%8.86M127.37%15.55M-10.63%27.75M0.72%8.41M-34.56%5.65M-12.38%6.85M9.48%6.84M25.12%31.05M24.95%8.35M
-Selling and marketing expense 142.07%4.63M183.34%5.1M259.85%10.38M-27.20%11M-11.45%4.41M-56.69%1.91M-46.54%1.8M22.41%2.88M66.18%15.11M94.57%4.98M
-General and administrative expense -12.80%3.26M-25.51%3.76M30.71%5.17M5.08%16.74M18.69%4M-11.47%3.74M13.52%5.05M1.65%3.95M1.36%15.93M-18.24%3.37M
Research and development costs -0.58%3.94M30.34%3.67M36.80%4.98M-53.76%14.36M-27.73%3.94M-41.04%3.96M-67.35%2.82M-64.52%3.64M-22.04%31.05M-48.46%5.45M
Operating profit -23.01%-11.83M-29.69%-12.53M-95.90%-20.52M31.09%-42.1M10.52%-12.35M37.40%-9.62M41.21%-9.66M32.42%-10.48M-2.44%-61.1M-0.30%-13.8M
Net non-operating interest income expense -152.54%-93K-245.48%-435K-295.08%-238K-58.74%583K-107.94%-15K-36.56%177K-23.92%299K-77.90%122K12.68%1.41M-67.53%189K
Non-operating interest income -19.07%874K-56.49%516K-29.88%697K4.97%4.16M-13.58%904K-3.57%1.08M-2.23%1.19M69.91%994K216.35%3.97M79.73%1.05M
Non-operating interest expense 7.09%967K7.22%951K7.22%935K40.21%3.58M7.23%919K7.37%903K8.17%887K2,542.42%872K--2.55M--857K
Other net income (expense)
Income before tax -26.31%-11.92M-38.48%-12.97M-100.51%-20.76M30.44%-41.52M9.17%-12.36M37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M
Income tax
Net income -26.31%-11.92M-38.48%-12.97M-100.51%-20.76M30.44%-41.52M9.17%-12.36M37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M
Net income continuous Operations -26.31%-11.92M-38.48%-12.97M-100.51%-20.76M30.44%-41.52M9.17%-12.36M37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M
Minority interest income
Net income attributable to the parent company -26.31%-11.92M-38.48%-12.97M-100.51%-20.76M30.44%-41.52M9.17%-12.36M37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -26.31%-11.92M-38.48%-12.97M-100.51%-20.76M30.44%-41.52M9.17%-12.36M37.41%-9.44M41.64%-9.36M30.74%-10.35M-2.22%-59.69M-3.29%-13.61M
Basic earnings per share 14.29%-0.12-42.86%-0.2-47.62%-0.3151.80%-0.6740.63%-0.1960.00%-0.1462.16%-0.1440.00%-0.21-0.72%-1.39-3.23%-0.32
Diluted earnings per share 14.29%-0.12-42.86%-0.2-47.62%-0.3151.80%-0.6740.63%-0.1960.00%-0.1462.16%-0.1440.00%-0.21-0.72%-1.39-3.23%-0.32
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +3.29%
Sample Name
Sample Code
 +1.71%
Sample Name
Sample Code
 +1.68%
4
Block
XYZ
+1.61%
5
Vistra Energy
VST
+1.12%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.73%
Sample Name
Sample Code
 +8.15%
Sample Name
Sample Code
 +4.18%
4
KE Holdings
BEKE
+3.90%
5
Pony AI
PONY
+3.84%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -